OTC · Drug Manufacturers - Specialty & Generic

Khiron Life Sciences Corp. (KHRNF) Stock

$0.00 OTC: KHRNF Healthcare

Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe.

Valuation

MetricValue
Price$0.00
Market Cap$2324
P/E Ratio-0.20
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.20
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-100.00%
ROA-78.57%
ROCE-64.62%
Gross Margin-153.85%
Operating Margin-153.85%
Net Margin-253.85%
Debt/Equity0.06
Current Ratio3.00

Annual Financials (USD)

Metric20172018201920202021
Revenue$0$1.0M$10.0M$8.0M$13.0M
Operating Profit$0$-20.0M$-37.0M$-24.0M$-20.0M
Net Profit$0$-20.0M$-36.0M$-24.0M$-33.0M
EPS$-0.16$-0.41$-0.36$-0.20$-0.20
Op Margin—-2231.3%-390.6%-294.4%-154.7%

Balance Sheet (USD)

Metric20172018201920202021
Total Assets$0$40.0M$82.0M$73.0M$42.0M
Total Liabilities$0$15.0M$12.0M$10.0M$9.0M
Cash$0$15.0M$9.0M$22.0M$9.0M
Borrowings$0$3.0M$4.0M$3.0M$2.0M

Cash Flow (USD)

Metric20172018201920202021
Operating Cash Flow$0$-15.0M$-30.0M$-25.0M$-20.0M
Investing Cash Flow$0$-13.0M$-38.0M$22.0M$-4.0M
Financing Cash Flow$0$15.0M$5.0M$12.0M$11.0M
Net Cash Flow$0$13.0M$-6.0M$12.0M$-13.0M
Free Cash Flow$0$-19.0M$-36.0M$-27.0M$-22.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.12
FCF Yield-243.20%
Quick Ratio1.86
Interest Coverage-50.18
Return 1Y0.00%
Return 3Y-99.93%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Khiron Life Sciences Corp.

Khiron Life Sciences Corp. operates as a comprehensive medical and cannabis enterprise, extending its operations across Latin America and Europe. The company's business is structured into three primary segments: Health Services, Medical Cannabis Products, and Wellbeing Products. A core focus for Khiron involves the end-to-end process of medical cannabis, encompassing the cultivation, manufacturing, distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) varieties. Additionally, the company manages a network of health centers and satellite clinics, notably under the ILANS and Zerenia brands. It also develops CBD-based cosmeceutical items, specifically marketed under its Kuida brand. Its healthcare footprint includes running Zerenia clinics in key locations such as Medellin and Peru. Khiron Life Sciences Corp. was founded in 2012 and maintains its corporate headquarters in Vancouver, Canada.

Khiron Life Sciences Corp. (KHRNF) stock trades at $0.00 with a market capitalization of $2324. The stock is valued at a price-to-earnings (P/E) ratio of -0.20, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Khiron Life Sciences Corp. generates a return on equity (ROE) of -100.00%, return on capital employed of -64.62%, an operating margin of -153.85%, a net profit margin of -253.85%.

Official website: khiron.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides